Avinger announces presentations by key opinion leaders at new cardiovascular horizons annual conference

Redwood city, ca / accesswire / june 9, 2023 / avinger, inc. (nasdaq:avgr), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced two podium presentations featuring the company's lumivascular technology at the new cardiovascular horizons (ncvh) annual conference, which took place may 30 through june 2 in new orleans. key opinion leaders in the fields of interventional cardiology and endovascular interventions highlighted avinger's lumivascular technology in the following sessions: dr. ian cawich, an interventional cardiologist at arkansas heart in little rock, highlighted the entire portfolio of avinger's proprietary oct-guided atherectomy technologies in his session, "oct-guided atherectomy of atk and btk lesions.
AVGR Ratings Summary
AVGR Quant Ranking